Cerus Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Cerus

Access the complete profile.

Cerus Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	325413 In-Vitro Diagnostic Substance Manufacturing 334516 Analytical Laboratory Instrument Manufacturing 541711 Research & Development in Biotechnology
Address	1220 Concord Ave Ste 600 Concord, CA 94520

Cerus's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Cerus's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Cerus is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Cerus is a publicly traded company on NGM using the ticker symbol CERS. Detailed information on company financials and operating reports can be found here: NGM: CERS

Cerus Annual Revenue and Growth Rate

Cerus	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Cerus's revenues are gauged from an analysis of company filings.

Trademark Applications

Trademark applications show the products and services that Cerus is developing and marketing. Cerus doesn't have any recent trademark applications, indicating Cerus is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
FIBRICEPT Medical devices for use in the preparation of pathogen inactivated blood products; blood processing apparatus, namely, blood processing devices; medical processing kits consisting primarily of medical tubing and containers for the production of pathogen reduced blood products; medical apparatus, namely, processing containers for cryoprecipitation and the production of cryoprecipitate, cryoprecipitated fibrinogen complex and cryoprecipitate reduced plasma	11/25/2020
INTERCEPT READY Compositions for use in the inactivation of pathogens in blood and blood components, namely, platelets, plasma and red blood cells for blood transfusions	08/28/2003

See all trademarks and details in the Full Report.

Market Share of Cerus's Largest Competitors

A competitive analysis shows these companies are in the same general field as Cerus, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Cerus. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
AOSENSE	Fremont, CA	100
EXELIXIS	Alameda, CA	83
10X GENOMICS	Pleasanton, CA	52
ASTRA SPACE OPERATIONS	Alameda, CA	27
NEURALINK	Fremont, CA	22
CERUS	Concord, CA	15

Future Competition: Cerus's Fastest Growing Competitors

These companies are in the same general field as Cerus and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)